← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

G

$ Value

$0

Shares

64,869

Price

$0

Filed

Mar 13

Insider

Name

Francois Cedric

Title

Chief Executive Officer

CIK

0001658080

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-11

Code

G

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

425,968

Footnotes

On March 11, 2026, the reporting person transferred 64,869 shares to The Cedric Francois Irrevocable Trust of 2023 - 2. Patrick Collins is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein. | The securities are held by The Cedric Francois Irrevocable Trust of 2023. Patrick Collins is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein. | The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois Grossi Trust except to the extent of his pecuniary interest therein. | The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001193125-26-106090

Form Type

4

Issuer CIK

0001492422

Francois Cedric's History

Date Ticker Type Value
2026-03-11 APLS G $0
2026-03-11 APLS G $0
2026-02-03 APLS M $33K
2026-02-03 APLS M $0
2026-01-28 APLS A $0
2026-01-22 APLS $592K
2026-01-20 APLS $162K
2026-01-13 APLS $226K
2025-08-28 APLS $1.4M
2025-08-27 APLS $4.9M

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28